HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Oriflame: After intensive research in the Arctic, firm says it is preparing to launch North for Men skin-care line formulated with Arctic Pro Defense featuring rhodiola root extract. A polar botanical "tough enough to thrive in extreme weather conditions," rhodiola is ideal for defending the male epidermis, company suggests. Loaded with antioxidants, the ingredient "protects skin against thermal stress and helps it adapt to internal and external aggressors," thereby putting off signs of aging, according to Oriflame. Line consists of Active Face Wash, Sensitive Skin Shaving Foam, Normal Skin Shaving Gel and After Shaving Moisture Balm. Oriflame Cosmetics is a key player in the growing Russian personal-care market, according to market researcher RNCOS (1"The Rose Sheet" June 30, 2008, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel